Effect of GLP1 agonists on reproduction
For a 5mg vial reconstituted with 2ml of bacteriostatic water, the concentration drops to 2.5mg/ml
During the initial month of Wegovy treatment, a 0.25 mg injection is utilized, in the second month - a 0.5 mg dose, in the third month - a 1 mg dose, in the fourth month - a 1.7 mg dose, and from the fifth month onwards - a 2.4 mg dose
Category 3 substances lack sufficient data for a full evaluation and remain under review
10.26355/eurrev_202001_20033 417 ZhangN.ZhuJ.MaQ.ZhaoY.WangY.HuX.et al (2020b)
#Pharmacy #Pharmacology #GLP1 #Semaglutide #Endocrinology #DiabetesCare #PharmaceuticalScience #MedicalAffairs #Obesity #ClinicalKnowledge It will be nice to explore the side effect profile os DPP-4 inhibitors compared to GLP-1 agonist as of todays use of GLP-1 and their higher doses to reduce body weight